Serenno Prepares US Launch Of Kidney Damage Detection Device
Executive Summary
Israeli start-up Serenno Medical is targeting 2020 for US FDA clearance and launch of its Sentinel device for early detection and prevention of acute kidney injury, a condition that affects 19 million patients worldwide every year.
You may also be interested in...
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.